Agios
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agios and other ETFs, options, and stocks.About AGIO
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology.
AGIO Key Statistics
Stock Snapshot
With a market cap of 1.59B, Agios(AGIO) trades at $27.27. The stock has a price-to-earnings ratio of -3.92.
On 2025-12-14, Agios(AGIO) stock traded between a low of $26.80 and a high of $27.67. Shares are currently priced at $27.27, which is +1.8% above the low and -1.4% below the high.
The Agios(AGIO)'s current trading volume is 1.16M, compared to an average daily volume of 1.29M.
During the past year, Agios(AGIO) stock moved between $22.24 at its lowest and $46.00 at its peak.
During the past year, Agios(AGIO) stock moved between $22.24 at its lowest and $46.00 at its peak.
AGIO News
In early December 2025, Agios Pharmaceuticals reported that the FDA missed its December 7 PDUFA goal date and has yet to issue a decision on the supplemental Ne...
Agios Pharmaceuticals (AGIO) is back in focus after the FDA missed its December 7 decision date on the mitapivat thalassemia sNDA, leaving the filing under acti...
Agios Pharma, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Emily Bodnar from H.C. Wainwright maintained a Buy rating on...
Analyst ratings
70%
of 10 ratingsMore AGIO News
Agios Pharmaceuticals (AGIO) announced that the U.S. Food and Drug Administration has not yet issued a regulatory decision on the supplemental New Drug Applicat...